These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3287734)

  • 1. [Value of anticoagulant therapy in deep venous thrombosis in the lower limb in elderly, mobilized patients. A double-blind placebo controlled study with open therapeutic guidance].
    Ott P; Eldrup E; Oxholm P
    Ugeskr Laeger; 1988 Jan; 150(4):218-21. PubMed ID: 3287734
    [No Abstract]   [Full Text] [Related]  

  • 2. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study].
    Prandoni P; Russo R; Pengo V; Boschello M; Casara D; Maddalena F; Schivazappa L
    Minerva Cardioangiol; 1986 Oct; 34(10):653-7. PubMed ID: 3543730
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant therapy.
    Coon WW
    Am J Surg; 1985 Oct; 150(4A):45-9. PubMed ID: 3901792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase or heparin in the management of patients with deep vein thrombosis?
    Kiil J; Carvalho A; Saksø P; Nielsen HO
    Acta Chir Scand; 1981; 147(7):529-32. PubMed ID: 7048826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
    Onarheim H; Lund T; Heimdal A; Arnesjø B
    Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of deep vein thrombosis of the lower limb: a comparison of arvin (Ancrod) and heparin by a double-blind technique.
    Davies JA; Merrick MV; Sharp AA; Holt JM
    Br J Haematol; 1972 May; 22(5):640. PubMed ID: 4555717
    [No Abstract]   [Full Text] [Related]  

  • 12. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study.
    Arnesen H; Høiseth A; Ly B
    Acta Med Scand; 1982; 211(1-2):65-8. PubMed ID: 7041523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose heparin therapy in the prevention of deep venous thrombosis in acute myocardial infarction. A controlled clinical trial].
    Remvig L; Mortensen SA; Als OS; Mentzel V; Holm G
    Ugeskr Laeger; 1983 Apr; 145(14):1053-6. PubMed ID: 6346624
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultra-low dose intravenous heparin in the prevention of postoperative deep vein thrombosis.
    Negus D; Friedgood A
    Phlebologie; 1982; 35(1):247-57. PubMed ID: 7041146
    [No Abstract]   [Full Text] [Related]  

  • 15. A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Hirsh J; Sackett DL
    JAMA; 1984 Jul; 252(2):235-9. PubMed ID: 6427492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 17. [The value of anticoagulant therapy in deep venous thrombosis].
    Nielsen HK; Geday E; Bechgaard P; Husted SE
    Ugeskr Laeger; 1981 Jul; 143(31):1947-51. PubMed ID: 7029841
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
    Wheeler AP; Jaquiss RD; Newman JH
    Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary resistance to heparin and warfarin in treatment of deep vein thrombosis.
    Viswanathan B
    J Kans Med Soc; 1980 Oct; 81(10):468-9. PubMed ID: 7229498
    [No Abstract]   [Full Text] [Related]  

  • 20. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.